Agilent to acquire BIOVECTRA
Agilent Technologies has signed a definitive agreement to acquire BIOVECTRA, a specialized contract development and manufacturing organization, for $925 million. Based in Canada, BIOVECTRA produces biologics, highly potent active pharmaceutical ingredients …